TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2305019

Group type: EXPERIMENTAL
Intervention: Hypnotic suggestion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical salicylic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment control
Number of subjects: 0
Study: 7288894

Group type: EXPERIMENTAL
Intervention: 800 IU vitamin E per day for 9 or more weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1600 IU vitamin E per day for 9 or more weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31843964

Group type: EXPERIMENTAL
Intervention: LPS infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 29667541

Group type: EXPERIMENTAL
Intervention: Synthetic absorbable monofilament sutures
Number of subjects: 107

Group type: COMPARATOR
Intervention: Synthetic absorbable multifilament sutures
Number of subjects: 107
Study: 28419192

Group type: EXPERIMENTAL
Intervention: Octohydroaminoacridine 1 mg TID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Octohydroaminoacridine 2 mg TID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Octohydroaminoacridine 4 mg TID
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose group (4 mg TID)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All drug groups
Number of subjects: 0
Study: 26577263

Group type: EXPERIMENTAL
Intervention: Coronary CTA-guided treatment strategy
Number of subjects: 598

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 598
Study: 23841565

Group type: EXPERIMENTAL
Intervention: Systane (right eye) and Eyestil (left eye)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Tears Naturale II (right eye) and Refresh Tears (left eye)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Eyestil
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Refresh
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Systane
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Tears Naturale
Number of subjects: 43
Study: 21335621

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional home monitoring with a blood glucose meter and masked continuous glucose monitor
Number of subjects: 120
Study: 19576623

Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine system (LNG‐IUS)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Surveillance group (Control)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Endometrial thickness at trial entry
Number of subjects: 113
Study: 17944585

Group type: EXPERIMENTAL
Intervention: oHo (olive oil mixture)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no oHo)
Number of subjects: 32
Study: 15008714

Group type: EXPERIMENTAL
Intervention: Intravesical BCG
Number of subjects: 1901

Group type: COMPARATOR
Intervention: Intravesical mitomycin C
Number of subjects: 1901

Group type: EXPERIMENTAL
Intervention: Intravesical BCG (27 mg)
Number of subjects: 1901

Group type: COMPARATOR
Intervention: Intravesical mitomycin C (30 mg)
Number of subjects: 1901
Study: 11339519

Group type: EXPERIMENTAL
Intervention: meloxicam 7.5 mg tablet
Number of subjects: 229

Group type: COMPARATOR
Intervention: diclofenac 100 mg slow release tablet
Number of subjects: 229
Study: 9217822

Group type: EXPERIMENTAL
Intervention: 0.1% tretinoin cream applied once a day for 1 week (n=10)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 0.1% tretinoin cream applied twice a day for 2 weeks (n=8)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 0.1% tretinoin cream applied once a day for 2 months (n=11)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Combination of betamethasone-17-valerate (once a day) and tretinoin (once a day)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Betamethasone-17-valerate (once a day)
Number of subjects: 29
Study: 8424571

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg intranasal midazolam
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.2 ml/5 kg placebo (distilled water)
Number of subjects: 40
Study: 3301712

Group type: EXPERIMENTAL
Intervention: Moderate energy intake plus exercise (MEEX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low energy intake without exercise (LESD)
Number of subjects: 0
Study: 30952217

Group type: EXPERIMENTAL
Intervention: Treadmill walking session for 50 minutes
Number of subjects: 40

Group type: COMPARATOR
Intervention: Quiet-rest control
Number of subjects: 40
Study: 27986096

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: iRoot BP Plus Root Repair Material (BP‐RRM)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 240
Study: 26422197

Group type: EXPERIMENTAL
Intervention: Lycopene-rich tomato extract (30 mg/day)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 22945416

Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 60
Study: 21494604

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01(E)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RTS,S/AS02(D)
Number of subjects: 0
Study: 18484235

Group type: EXPERIMENTAL
Intervention: Interferon beta-1b (IFNbeta)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 16565955

Group type: COMPARATOR
Intervention: Normal-appearing white matter (NAWM) in MS patients
Number of subjects: 64

Group type: COMPARATOR
Intervention: Cortical gray matter (NAGM) in MS patients
Number of subjects: 64

Group type: COMPARATOR
Intervention: Regional analyses of NAWM
Number of subjects: 64

Group type: COMPARATOR
Intervention: Regional analyses of NAGM
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: NAGM-ADC histogram peak height in RR/SPMS patients
Number of subjects: 64
Study: 15276894

Group type: EXPERIMENTAL
Intervention: Lecture plus standardized patient instructors and small-group sessions
Number of subjects: 200

Group type: COMPARATOR
Intervention: Lecture alone
Number of subjects: 200
Study: 10649159

Group type: EXPERIMENTAL
Intervention: Perineal massage (10-minute daily massage from 34th to 35th weeks of pregnancy until delivery)
Number of subjects: 759

Group type: COMPARATOR
Intervention: Control group (no perineal massage)
Number of subjects: 759

Group type: EXPERIMENTAL
Intervention: Perineal massage
Number of subjects: 759

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 759
Study: 9278798

Group type: EXPERIMENTAL
Intervention: rimexolone 1% ophthalmic suspension
Number of subjects: 197

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 197
Study: 8348392

Group type: EXPERIMENTAL
Intervention: Lovastatin (20 mg/day, increased to max 80 mg/day)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Simvastatin (10 mg/day, increased to max 40 mg/day)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Lovastatin
Number of subjects: 298

Group type: COMPARATOR
Intervention: Simvastatin
Number of subjects: 298
Study: 3799503

Group type: EXPERIMENTAL
Intervention: Se-supplemented group (20 micrograms Se/L)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Unsupplemented group (3-5 micrograms Se/L)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Breast-fed group
Number of subjects: 32
Study: 31682472

Group type: EXPERIMENTAL
Intervention: Bleomycin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Candida albicans antigen
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU)
Number of subjects: 60
Study: 31570084

Group type: EXPERIMENTAL
Intervention: Low-dose tirofiban treatment within the first 24 hours after IVT
Number of subjects: 187
Study: 28080180

Group type: EXPERIMENTAL
Intervention: Five years of tamoxifen
Number of subjects: 4128

Group type: COMPARATOR
Intervention: Two years of tamoxifen
Number of subjects: 4128
Study: 26130744

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus carboplatin (10 mg/kg every 2 weeks and carboplatin AUC 5 every 4 weeks)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Bevacizumab monotherapy (10 mg/kg every 2 weeks)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus carboplatin
Number of subjects: 122

Group type: COMPARATOR
Intervention: Bevacizumab monotherapy
Number of subjects: 122
Study: 23319527

Group type: EXPERIMENTAL
Intervention: Physical activity (PA) measured by 7-day accelerometry (counts per minute, cpm)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Physical activity (PA)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Moderate-vigorous physical activity
Number of subjects: 182

Group type: COMPARATOR
Intervention: Sedentary activity
Number of subjects: 182

Group type: COMPARATOR
Intervention: Light activity
Number of subjects: 182
Study: 21039930

Group type: EXPERIMENTAL
Intervention: ALA and VC supplementation (ALA: 0, 5, 10 mg/kg; VC: 0, 500 mg/kg)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: ALA and VC supplementation
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: ALA supplementation
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: ALA or VC supplementation
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: VC supplementation
Number of subjects: 252
Study: 19609181

Group type: EXPERIMENTAL
Intervention: Group reminiscence sessions (6 to 8 sessions over 2 months)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 45
Study: 17569876

Group type: EXPERIMENTAL
Intervention: NXY-059
Number of subjects: 607

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 607
Study: 15056525

Group type: EXPERIMENTAL
Intervention: Triazolam (a short-acting benzodiazepine)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 11472243

Group type: EXPERIMENTAL
Intervention: Antitumor prodrug monotherapy targeting tumor-associated factors (hypoxia, enzymes, receptors)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prodrugs designed for direct recognition of tumor-associated factors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prodrugs targeting elevated levels of beta-glucuronidase and tumor-associated proteases
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Receptor-binding motifs coupled to cytotoxic drugs
Number of subjects: 0
Study: 9448149

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (3 million U three times weekly for 6 months)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no prophylaxis)
Number of subjects: 24
Study: 7612090

Group type: EXPERIMENTAL
Intervention: Double phototherapy (n = 19) with irradiance of 33 to 35 microW/cm2/nm in addition to single conventional phototherapy with combination of three or four special blue and white lamps with irradiance of 7 to 9 microW/cm2/nm
Number of subjects: 42

Group type: COMPARATOR
Intervention: Single conventional phototherapy (n = 23)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Double phototherapy (n = 19)
Number of subjects: 42
Study: 2803885

Group type: EXPERIMENTAL
Intervention: Warmed group (normothermia)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cold group (routine care)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 12
Study: 594652

Group type: EXPERIMENTAL
Intervention: Metrizamide (non-ionic contrast medium)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Metrizoate (dissociable contrast medium)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both contrast media
Number of subjects: 12
Study: 31630816

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 802

Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Non-DM (NDM) patients
Number of subjects: 802
Study: 28167849

Group type: EXPERIMENTAL
Intervention: Vitamin supplementation (A, B12, C, D, E, K)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin A, C, D, E
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin A, B12, C, D, K
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin D
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin A, D, E, K
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin A, C, E
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin B12
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin K
Number of subjects: 0
Study: 25740691

Group type: EXPERIMENTAL
Intervention: Balugrastim 300 µg/kg
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Balugrastim 450 µg/kg
Number of subjects: 51

Group type: COMPARATOR
Intervention: Pegfilgrastim 6 mg
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Balugrastim (both doses)
Number of subjects: 51
Study: 23404963

Group type: EXPERIMENTAL
Intervention: 2 PMR/day
Number of subjects: 36

Group type: COMPARATOR
Intervention: 1 PMR/day
Number of subjects: 36
Study: 22017794

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PF-03882845
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eplerenone and PF-03882845
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Urinary Na+/K+ and plasma aldosterone
Number of subjects: 0
Study: 19842460

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention to increase physical activity (PA) and reduce sedentary behavior
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Baseline measures of PA and TV viewing behaviors
Number of subjects: 30
Study: 17341775

Group type: EXPERIMENTAL
Intervention: Step-up and step-down sizing
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard sizing
Number of subjects: 25
Study: 15481065

Group type: EXPERIMENTAL
Intervention: Kit-based activity intervention
Number of subjects: 37

Group type: COMPARATOR
Intervention: Time and attention control (one-on-one meetings with an activity therapist)
Number of subjects: 37
Study: 11578894

Group type: EXPERIMENTAL
Intervention: Structured preoperative education on the use of PCA
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard information given during routine preanesthetic assessment
Number of subjects: 60
Study: 9643663

Group type: EXPERIMENTAL
Intervention: Casodex 150 mg/day
Number of subjects: 1453

Group type: COMPARATOR
Intervention: Castration
Number of subjects: 1453
Study: 7930237

Group type: EXPERIMENTAL
Intervention: Aspirin plus dipyridamole
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Oral anticoagulant agents
Number of subjects: 494

Group type: COMPARATOR
Intervention: Low dose aspirin (50 mg/day)
Number of subjects: 494
Study: 2739826

Group type: EXPERIMENTAL
Intervention: Low-dose dopamine infusion (0.1 microgram/kg/min) + hydrosaline retention
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Retention + dl-sulpiride (n = 8)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Retention + d-sulpiride (n = 7)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Retention + l-sulpiride (n = 7)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Low-dose dopamine infusion (0.1 microgram/kg/min)
Number of subjects: 23
Study: 31900169

Group type: EXPERIMENTAL
Intervention: Robotic device for hand rehabilitation measuring finger strength (flexion and extension)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Robotic device for hand rehabilitation measuring spasticity
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Robotic device for hand rehabilitation
Number of subjects: 120
Study: 31515667

Group type: EXPERIMENTAL
Intervention: 500 mg abiraterone acetate taken with a continental breakfast (CB)
Number of subjects: 14

Group type: COMPARATOR
Intervention: 1000 mg abiraterone acetate taken fasted
Number of subjects: 14
Study: 28574605

Group type: EXPERIMENTAL
Intervention: Folic acid (0.8 mg) plus vitamin B12 (0.4 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin B6 (40 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26509152

Group type: EXPERIMENTAL
Intervention: High-Volume Low-Pressure (HVLP) cuffs
Number of subjects: 40

Group type: COMPARATOR
Intervention: Taper-shaped cuffs
Number of subjects: 40
Study: 23802809

Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 3562

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3562
Study: 21972411

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control
Number of subjects: 360
Study: 19821989

Group type: EXPERIMENTAL
Intervention: Systematic family history recording
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lifestyle advice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Behavioural interventions targeted at 'at risk' patients
Number of subjects: 0
Study: 17224033

Group type: EXPERIMENTAL
Intervention: Diode laser irradiation at 810 nm for 20 seconds
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Diode laser irradiation at 980 nm for 20 seconds
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Diode laser irradiation at 810 nm, repeated 5 times for 20 seconds
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Diode laser irradiation at 980 nm, repeated 5 times for 20 seconds
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Diode laser irradiation in pulsed mode
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (non-irradiated sleeves)
Number of subjects: 22
Study: 15499821

Group type: EXPERIMENTAL
Intervention: Mere inflation condition (eyewitness confidence increased over time)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Inflation + challenge condition (eyewitness aggressively challenged about confidence change)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control condition (no evidence of confidence inflation)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Hispanic participants (N = 360)
Number of subjects: 450
Study: 11556942

Group type: EXPERIMENTAL
Intervention: Physician education on diagnosis and optimal management of depression over a 3-month training period.
Number of subjects: 124893
Study: 9785069

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 30

Group type: COMPARATOR
Intervention: 2% mepivacaine
Number of subjects: 30
Study: 7908531

Group type: EXPERIMENTAL
Intervention: MK-467
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3285633

Group type: EXPERIMENTAL
Intervention: Dehydrobenzperidol (DHBP) during premedication
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Dehydrobenzperidol (DHBP) during induction of anesthesia
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Dehydrobenzperidol (DHBP) when patients presented symptoms of nausea and/or vomiting
Number of subjects: 206

Group type: COMPARATOR
Intervention: No dehydrobenzperidol (Control group)
Number of subjects: 206
Study: 31775396

Group type: EXPERIMENTAL
Intervention: Whole mixed berries
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sugar matched mixed berry juice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sugar matched gelatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sugar/fiber matched gelatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined berry preparations
Number of subjects: 0
Study: 27083384

Group type: EXPERIMENTAL
Intervention: Tryton Stent
Number of subjects: 159

Group type: COMPARATOR
Intervention: Side Branch Balloon Angioplasty (SBBA)
Number of subjects: 159
Study: 26639027

Group type: EXPERIMENTAL
Intervention: Nelfilcon A (NF)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Delefilcon A (DF)
Number of subjects: 76
Study: 24002584

Group type: EXPERIMENTAL
Intervention: Tumescent suction curettage
Number of subjects: 22

Group type: COMPARATOR
Intervention: Curettage only
Number of subjects: 22
Study: 23939405

Group type: EXPERIMENTAL
Intervention: Body vibration
Number of subjects: 23

Group type: COMPARATOR
Intervention: No vibration (control)
Number of subjects: 23
Study: 19293172

Group type: EXPERIMENTAL
Intervention: Galantamine (4 month, randomised, placebo controlled trial)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo (4 month, randomised, placebo controlled trial)
Number of subjects: 130
Study: 17515173

Group type: EXPERIMENTAL
Intervention: Citalopram (flexible dosage)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Reboxetine (varying dosage)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 37
Study: 15466324

Group type: EXPERIMENTAL
Intervention: Surgical drainage
Number of subjects: 7

Group type: COMPARATOR
Intervention: Antibiotic treatment
Number of subjects: 7
Study: 11357303

Group type: EXPERIMENTAL
Intervention: Adehl (colforsin daropate hydrochloride) infusion (0.5 microgram.kg‐1.min‐1 for 6 hours)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no Adehl treatment)
Number of subjects: 26
Study: 9483471

Group type: EXPERIMENTAL
Intervention: Room air hyperventilation
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5% CO2 breathing
Number of subjects: 0

Group type: COMPARATOR
Intervention: 7% CO2 breathing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Panic disorder patients (general)
Number of subjects: 0
Study: 7509259

Group type: EXPERIMENTAL
Intervention: L-NMMA (0.3 and 1 mg.kg-1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: L-NMMA (1 mg.kg-1 x h-1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: L-NMMA (highest dose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3177072

Group type: EXPERIMENTAL
Intervention: Expectancy manipulation (alcohol beverage information)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Attention demanding tasks
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Alcohol doses (0.0; 0.4; 0.6 g/kg)
Number of subjects: 79
Study: 31099727

Group type: EXPERIMENTAL
Intervention: Phytosterol Supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28271073

Group type: EXPERIMENTAL
Intervention: Sorafenib (first-line therapy)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Sorafenib (all patients)
Number of subjects: 177
Study: 26354521

Group type: EXPERIMENTAL
Intervention: mDCF (docetaxel 40 mg/m2 day 1, leucovorin 400 mg/m2 day 1, 5FU 400 mg/m2 bolus day 1, 5FU 1000 mg/m2/d days 1 and 2, cisplatin 40 mg/m2 day 3)
Number of subjects: 56

Group type: COMPARATOR
Intervention: EOX (epirubicin 50 mg/m2 day 1, oxaliplatin 130 mg/m2 day 1, capecitabine 1250 mg/m2/d days 1-21)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: mDCF
Number of subjects: 56

Group type: COMPARATOR
Intervention: EOX
Number of subjects: 56